Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
5 Results for "
phase change cycles
" in MedChemExpress (MCE) Product Catalog:
Products (5)
5 Results for "phase change cycles" in MCE Product Catalog:
23
23 Cited Publications
Synonyms: bisBenzimide H 33258; H 33258
Cat. No.: HY-W094846
CAS No.: 629-59-4
Synonyms: n-Tetradecane
Research Areas:
Tetradecane (n-Tetradecane) is a low-temperature phase change material with a phase change temperature of 5°C and a latent heat of phase change of 220 J/g. Tetradecane undergoes solid-liquid phase transition around 5°C, and achieves temperature regulation by absorbing or releasing latent heat .
Cat. No.: HY-168072
CAS No.: 2955243-69-1
Target:
Research Areas:
GP130-IN-1 (compound 49) is a potent GP130 inhibitor with significant in vitro antitumor activity and higher selectivity than Bazedoxifene (HY-A0031). GP130-IN-1 induces ultrastructural changes in cells, causing cell cycle arrest in the G0/G1 phase in a time-dependent manner and triggering apoptosis and autophagy. GP130-IN-1 can be used in the study of triple-negative breast cancer .
Cat. No.: HY-W094110
CAS No.: 10028-22-5
Research Areas:
Iron (III) sulfate is a stable rhombohedral NASICON compound. Iron (III) sulfate can serve as a sodium ion intercalation host, enabling sodium ion intercalation and deintercalation via a single-phase mechanism relying on the Fe 2+/Fe 3+ redox couple. Iron (III) sulfate exhibits reversible electrochemical behavior and moderate polarization in cyclic voltammetry tests, and its charge transfer resistance changes during charge-discharge cycles. Iron (III) sulfate possesses a high redox potential, excellent rate capability, and long-cycle stability .
Cat. No.: HY-183456
CAS No.: 71308-35-5
Research Areas:
Tyrphostin AG17 is an orally active CDK2 inhibitor and EGFR tyrosine kinase antagonist. Tyrphostin AG17 reduces the levels of p21 and p16. Tyrphostin AG17 induces G1 phase cell cycle arrest, Apoptosis, mitochondrial dysfunction, decreased ATP levels, and inhibits DNA, RNA and protein synthesis, adipogenesis, and lipid synthesis. Tyrphostin AG17 inhibits fat accumulation, white adipose tissue hypertrophy, and alterations of glycogen and lipid inclusions in hepatocytes in obese mice without changing their serum biochemical parameters. Tyrphostin AG17 exhibits anticancer effects. Tyrphostin AG17 can be used in research related to immunoblastic lymphoma, leukemia, ovarian cancer, glioblastoma, colon cancer, breast cancer, melanoma, obesity and hepatic steatosis .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
